Expression of programmed death ligand 1 (PD-L1) in malignant and nonmalignant pancreatic tissue

被引：4
|
作者：
Razzaque, Saqib [1 ]
Ashraf, Noman [1 ]
Chavez, Julio C. [1 ]
Malafa, Mokenge Peter [1 ]
Coppola, Domenico [1 ]
Springett, Gregory M. [1 ]
Helm, James [1 ]
Kim, Richard D. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
215
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Programmed death receptor ligand-1 (PD-L1) expression in a thymoma (T) tissue microarray (TMA)
    Padda, Sukhmani Kaur
    Riess, Jonathan
    Schwartz, Erich Jurgen
    Tian, Lu
    Kohrt, Holbrook Edwin
    Neal, Joel W.
    Natkunam, Yasodha
    West, Robert B.
    Wakelee, Heather A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [33] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    [J]. Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [34] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1127 - 1127
  • [35] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [36] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN TYPE 2 ENDOMETRIAL CANCER
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 220 - 220
  • [37] Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma
    Gulec, Umran Kucukgoz
    Bagir, Emine Kilic
    Paydas, Semra
    Guzel, Ahmet Baris
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 244 : 51 - 55
  • [38] Programmed Death Ligand (PD-L1) Expression Is Increased in Spleens of Myelofibrosis Patients
    Craig, Ryan
    Tripp, Sheryl R.
    Deininger, Michael
    Salama, Mohamed E.
    [J]. MODERN PATHOLOGY, 2016, 29 : 341A - 341A
  • [39] Programmed Death Ligand (PD-L1) Expression Is Increased in Spleens of Myelofibrosis Patients
    Craig, Ryan
    Tripp, Sheryl R.
    Deininger, Michael
    Salama, Mohamed E.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 341A - 341A
  • [40] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    [J]. EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
12345